On March 2, ASCO will hold its first-ever Oncology Practice Conference in Orlando, Florida. The event will focus on the regulatory, administrative, and legal challenges faced by oncology practices. Specific topics to be covered include MACRA, lessons in sustaining a practice, alternate payment models, and addressing physician burnout. Advanced registration rates end Feb. 17.
The 2017 Cancer Survivorship Symposium Virtual Meeting provides users with access to the practice-changing science and education from the Symposium through videos, presentation slides, abstracts, podcasts, and the iMeeting App. Search for sessions by speaker, session name, presentation title, or abstract number.
At the 2017 GU Cancers Symposium, researchers presented a study that found that prostate cancer can be subtyped based on cell of origin, into luminal A, luminal B, and basal cell subtypes. Luminal B prostate cancer has the poorest prognosis, but also derives the most benefit from ADT.
Searching for an abstract? Looking for a Virtual Meeting video from a session you missed? Find these resources and more at ASCO’s Meeting Library. Access the archives to watch and listen to expert faculty discuss the latest multidisciplinary research, treatment, and care presented during the world-renowned ASCO Annual Meeting. Find exactly what you’re looking for searching by content type.
ASCO Symposia bring together specialists from around the world to offer educational content and the latest scientific discoveries in the respective fields, while providing ample time for networking and collaboration. Upcoming Symposia include the Palliative Care in Oncology Symposium, Gastrointestinal Cancers Symposium, Cancer Survivorship Symposium: Advancing Care in Research, Genitourinary Cancers Symposium and more.
The 2016 Annual Meeting brought together over 30,000 oncology professionals from around the world. Join us next year in Chicago at the 2017 Annual Meeting, featuring world-renowned faculty and educational sessions about state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.